Author Archive

Dr. Mark Hyman Rapaport to give Dorothy C. Fuqua Lecture

Monday, October 10th, 2011

We are so excited that Mark Hyman Rapaort, MD, Chair of the Department of Psychiatry and Behaviroal Sciences at Emory University School of Medicine will be giving this year’s inaugural Dorothy C. Fuqua Lecture Series.  Information can be found at: http://skylandtrail.org/dorothy-c-fuqua-lecture-series.

I had a chance to ask Dr. Rapaport some questions about his new role at Emory and what changes he sees on the horizon for mental health treatment. That discussion is below. We hope to see you on October 26th for the lecture!

Sincerely,

Ray Kotwicki, MD, MPH

Vice President of Professional Services/Medical Director

Ray: What attracted you to come to Atlanta to lead Emory’s Department of Psychiatry and Behavioral Sciences?  What do you envision as a “Transformed” mental health community in Atlanta and the Southeast?

Dr. Rapaport: “I was struck by the excellence of science at Emory, not just in the Department of Psychiatry but throughout the entire University. It is a first rate science institution.

“Emory has a sense of values: there are values on people being collaborative, rigorous, and on having integrity and honesty-I was impressed. People are nice, genuinely warm and friendly and willing to work together.

“I think there is tremendous opportunity in Atlanta to grow collaboratively with the community. This is a place that can be truly remarkable for the treatment of people with brain diseases.”

Ray: Given that many people who could benefit from mental health services do not access them due to stigma, what strategies might decrease that barrier and encourage people to seek treatment when needed?

Dr. Rapaport: “If we’re talking about what our patients need, there are a variety of things that are apparent. Services need to be located where the people are, so that they’re not traveling long distances and that there aren’t barriers due to financial concerns, the weather or transportation issues.

 “There does need to be a breaking down of the idea that diseases of the brain are somehow different than the rest of the body—they are as real and as deadly as heart disease or cancer and they need to be legitimized by everyone in our community. They also need to be understood as a physical illness with tremendous costs associated with them in terms of human suffering, suffering of family members and friends, and the dollar amount tied to them.

“Two things we can do are to put treatment facilities where the patients are and break down the stigma by having people understand that these are legitimate diseases—not personality failings or individual weakness.”

Ray: You have trained and led large organizations in California.  What differences do you see between the mental health system on the West Coast and that we have in Georgia?

Dr.Rapaport: “One of the things that is remarkable in Georgia is the availability and willingness of the leaders to meet with the people.  There are also seems to be a desire right now for consumer advocates in the state level to really want to partner with academic institutions to create a viable system that will take care of people with severe mental illness.”

 Ray: Skyland Trail and Emory have had a close and symbiotic relationship in our 22-year history.  In what ways do you think Skyland Trail is integral to the mental health community and how might  Emory and Skyland Trail further develop our relationship in years ahead?

Dr.Rapaport: “I respect what Skyland Trail has done. It has, I think, provided outstanding care to the local community and has done so in a way that’s ethical and innovative and I’m looking forward to creating further bridges between Emory and Skyland Trail. I think that working together we can truly make tremendous improvements for everyone in Atlanta.

“We have the opportunity to create, through mutual respect, innovative models of care and training that will truly benefit patients in Georgia. I also think that there’s an opportunity to link up research strengths of Emory with the clinical strength of Skyland Trail in ways where they sum is greater than the parts. I’m excited by the opportunity to work collaboratively on research projects, projects of interest to larger Atlanta community and, by working together, we can make a difference throughout the state.

Ray: We’ve learned about recent bullying-related suicides, morbidity resulting from losses in the economy, and exploding misuses of substances through the media.  What do see to be the largest mental health challenges the public face today? 

Dr. Rapaport: “I think really the largest mental health challenge we face today is having all of our various constituents—those who make policy or reimburse policy, those who create and form policy, as well as the constituents who are our patients—appreciate the importance and the consequences of diseases of the brain. The mind and the body are connected by the neck and if one has depression, one is more likely to develop cardiac disease. If one has chronic stress, they are more likely to have chronic markers of immune activation and inflammation.”

“Brain diseases are a serious illness deserve the same type of funding and attention as cancer or heart disease or diabetes. We need to get out the word. I think that is the greatest challenge we face.”

Ray Kotwicki

New Director of Outcomes and Research

Friday, August 19th, 2011

Please join me in welcoming Dr. Kimberly Farris, PhD, MSW to Skyland Trail as our new Director of Research and Outcomes.  Dr. Farris is a consummate research scholar, with many published peer-reviewed journal articles, academic presentations, and health outcomes education. 

Dr. Farris received her undergraduate degree in Psychology from the University of Georgia and her Master of Social Work degree with a Health/Mental Health concentration from Clark Atlanta University.  She completed her doctoral studies in Social Work at The University of Texas at Austin School of Social Work.  Upon graduation from UT Austin, Dr. Farris completed a three year biomedical postdoctoral fellowship awarded by the National Institutes of Health at the University of Pennsylvania School of Medicine in the Department of Psychiatry.  Currently, she is pursuing a Master of Public Health degree with a Prevention Research focus from Emory University’s Rollins School of Public Health.  She also has previous clinical experience through her work in residential treatment services for adolescents receiving mental health care, foster care, and various health care settings.  She is an active member in evaluation and public health focused professional organizations including the American Evaluation Association, American Public Health Association, and others.  Her research areas of interest include examining the role of spirituality in mental health treatment and evaluating the use of traditional and non‐traditional education, prevention and intervention strategies for public health issues including health/mental health care and substance abuse, provided by community‐based organizations as well as multi‐ level health and mental health programs and systems.

Dr. Farris will work directly with me and many other staff to identify and chart a strategy to share the good word about Skyland Trail nationally, and to ask important questions about the services we provide to our patients.  Dr. Farris is passionate about this work and very interested in the linkages between health and race, spirituality, public health, and substance use.

Dr. Farris adds another layer of expertise to our team of experts.  We are thrilled she’s here.

Sincerely,

Ray Kotwicki, MD, MPH
Vice President of Professional Services/Medical Director

Ray Kotwicki

Welcome Dr. Fitzgerald!

Friday, August 5th, 2011

Skyland Trail is pleased to welcome Dr. Kimberly Fitzgerald, a third-year Emory psychiatry resident, to our clinical team. She will serve as the primary psychiatrist for patients in our CBT track, under the supervision of Drs. Burns and Chavez.

Emory School of Medicine has partnered with Skyland Trail for this important training, and we look forward to having Dr. Fitzgerald here with us.

Dr. Fitzgerald is a graduate from the University of Florida Medical School has trained at the Betty Ford Clinic, and is finishing her specialty training in psychiatry at Emory.

Dr. Fitzgerald says she was attracted to Skyland Trail because of our unique model of care, which relies on the entire treatment team.

“I think being able to see patients regularly is helpful for getting feedback from a number of different members of the team, who all bring their own level of expertise and perspectives to the table,” Dr. Fitzgerald says. “Here, you’re not making a treatment plan in a vacuum, you can see everything about the patient. It’s very helpful to have a team to be able to point out your own strengths.”

 Skyland Trail’s approach to care was also a draw for Dr. Fitzgerald.

“I also really like being able to have a holistic perspective, including exercise, nutrition and spirituality,” she says. “It’s nice to be able to learn from this.”

 Dr. Fitzgerald is an accomplished artist who has an undergraduate degree in art history from Yale. She enjoys painting marine life and science-inspired works, and says she is looking forward to interacting with the adjunctive therapy team at Skyland Trail.

“I love that Skyland Trail places value on the artistic and creative process and how it is helpful both with insight and therapeutically,” she said. “I have a lot to learn, and I’m looking forward to it.”

Dr. Fitzgerald enjoys exploring Atlanta, doing activities like hiking and kayaking that she didn’t do growing up in Miami.  

Dr. Fitzgerald (right), with Skyland Trail President Beth Finnerty, and Dr. Ann Schwartz (left)

Ray Kotwicki

Changes to Admission Process at Skyland Trail

Tuesday, February 1st, 2011

Starting today, Skyland Trail will be using a different diagnostic test at admission. Currently, we are using the “SCID,” which takes roughly two hours to complete. Now, our admissions staff will be using a new tool called the “MINI.”

This is an exciting start to our outcomes and research program.  We learned that since using the SCID at admission for all patients, the number of diagnostic changes between admission and discharge have plummeted -which is great.  However, using the SCID at admission is a lengthy process and consumes a lot of valuable time.  

A tool developed by Sheehan named the MINI is thought to provide almost equally valid and specific diagnostic clarity as the SCID.  It requires 15 minutes to complete which makes it much more community friendly.  The switch from SCID to MINI at Skyland will allow for us to compare changes in diagnoses between three groups: 1) patients admitted prior to 8/09 who had no admission diagnostic tool screenings (but whose diagnoses were frequently changed based on clinical observations), 2) patients admitted between 8/09 and 2/11 who used the SCID, and 3) patients admitted after 2/11 who had the MINI.  If we can demonstrate that the MINI yields as good results as the SCID, we might be able to advocate for its use in community mental health settings where often there is diagnostic uncertainty.

Dr. Phil Harvey, a member of Skyland Trail’s National Advisory Board who also serves as Professor of Psychiatry and Behavioral Sciences and Director of the Division of Psychology at the University of Miami Miller School of Medicine, is helping us embark on this change. He’s also advising us on several  other research projects that aim to answer similar questions that contribute to the use of evidence-based psychiatric practice across the country.   

We look forward to using this new tool to further increase the services we are providing to our clients and their families.

Sincerely,

Dr. Ray Kotwicki

Vice President of Professional Services and Medical Director

Ray Kotwicki